Lensar (LNSR) Free Cash Flow (QoQ) (2020 - 2026)
Lensar (LNSR) Free Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.10 Bn | 7.27 Bn |
| 2 | Stryker | 127.86 Bn | 124.38 Bn | 4.50 Bn |
| 3 | Medtronic | 119.05 Bn | 109.83 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.61 Bn | 73.07 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.00 Bn | 47.75 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.42 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.85 Bn | 31.74 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.38 Bn | 23.06 Bn | 4.55 Bn |
| 9 | Steris | 23.08 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Lensar | 102.19 Mn | 88.62 Mn | 9.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 97.03% |
| Mar 31, 2026 | -791.10% |
| Dec 31, 2025 | 117.59% |
| Sep 30, 2025 | 30.78% |
| Jun 30, 2025 | 26.92% |
| Mar 31, 2025 | -290.04% |
| Dec 31, 2024 | 16.63% |
| Sep 30, 2024 | 182.34% |
| Jun 30, 2024 | 29.71% |
| Mar 31, 2024 | -931.05% |
| Dec 31, 2023 | -53.96% |
| Sep 30, 2023 | 85.33% |
| Jun 30, 2023 | 65.32% |
| Mar 31, 2023 | -39.23% |
| Dec 31, 2022 | -2.38% |
| Sep 30, 2022 | -67.96% |
| Jun 30, 2022 | -5.54% |
| Mar 31, 2022 | -196.42% |
| Dec 31, 2021 | 61.02% |
| Sep 30, 2021 | -64.12% |